feed,title,long_url,short_url
Benzinga,Precision BioSciences' CD-19 CAR T Therapy Shows Response Rate Of 77% In Lymphoma Trial,https://benzinga.com/general/biotech/21/05/21221372/precision-biosciences-cd-19-car-t-therapy-shows-response-rate-of-77-in-lymphoma-trial,https://j.mp/2RCFPNn
